U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H19N3O4S
Molecular Weight 397.448
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Sipagladenant

SMILES

CC1=NC=C(C=C1)C(=O)NC2=NC(C3=CC=CO3)=C(S2)C(=O)C4CCOCC4

InChI

InChIKey=KMFLQPJJHQNKKF-UHFFFAOYSA-N
InChI=1S/C20H19N3O4S/c1-12-4-5-14(11-21-12)19(25)23-20-22-16(15-3-2-8-27-15)18(28-20)17(24)13-6-9-26-10-7-13/h2-5,8,11,13H,6-7,9-10H2,1H3,(H,22,23,25)

HIDE SMILES / InChI

Molecular Formula C20H19N3O4S
Molecular Weight 397.448
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 05:45:41 UTC 2023
Edited
by admin
on Sat Dec 16 05:45:41 UTC 2023
Record UNII
FF2012ZV92
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Sipagladenant
INN  
Official Name English
KW-6356
Code English
sipagladenant [INN]
Common Name English
3-PYRIDINECARBOXAMIDE, N-(4-(2-FURANYL)-5-((TETRAHYDRO-2H-PYRAN-4-YL)CARBONYL)-2-THIAZOLYL)-6-METHYL-
Systematic Name English
KW6356
Code English
N-[4-(furan-2-yl)-5-(oxane-4-carbonyl)-1,3-thiazol-2-yl]-6-methylpyridine-3-carboxamide
Systematic Name English
Code System Code Type Description
CAS
858979-50-7
Created by admin on Sat Dec 16 05:45:41 UTC 2023 , Edited by admin on Sat Dec 16 05:45:41 UTC 2023
PRIMARY
SMS_ID
300000037065
Created by admin on Sat Dec 16 05:45:41 UTC 2023 , Edited by admin on Sat Dec 16 05:45:41 UTC 2023
PRIMARY
NCI_THESAURUS
C190445
Created by admin on Sat Dec 16 05:45:41 UTC 2023 , Edited by admin on Sat Dec 16 05:45:41 UTC 2023
PRIMARY
PUBCHEM
23144148
Created by admin on Sat Dec 16 05:45:41 UTC 2023 , Edited by admin on Sat Dec 16 05:45:41 UTC 2023
PRIMARY
INN
12173
Created by admin on Sat Dec 16 05:45:41 UTC 2023 , Edited by admin on Sat Dec 16 05:45:41 UTC 2023
PRIMARY
FDA UNII
FF2012ZV92
Created by admin on Sat Dec 16 05:45:41 UTC 2023 , Edited by admin on Sat Dec 16 05:45:41 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
IC50
TARGET->INVERSE AGONIST
EC50
Related Record Type Details
ACTIVE MOIETY